Purdue Pharma is working with advisers on a possible bankruptcy filing as it seeks to contain liability from suits alleging it fueled the U.S. opioid epidemic.

Sections:  world   
Topics:  asia   
RELATED ARTICLES
BING NEWS:
  • Opioid Maker Avoids Massive Federal Penalty Through Bankruptcy, Slow-Moving DOJ
    Mallinckrodt, the nation’s biggest opioid pill maker, agreed to pay $1.7 billion in opioids damages in 2022 in its first bankruptcy. It filed a second bankruptcy last year and cut its payment to $700 ...
    12/17/2024 - 4:13 am | View Link
  • McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales
    McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia ...
    12/13/2024 - 7:06 am | View Link
  • How New Jersey’s Pragmatic Bankruptcy Approach Sets It Apart Post-'Purdue Pharma'
    The Chapter 11 filing statistics clearly show that New Jersey has emerged as a strong venue option. The question is why? The answer, we submit, is consistency and pragmatism.
    12/11/2024 - 3:00 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News